REFERENCES
- Eisenberg SP, Evans RJ, Arend WP et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990;343:341–346.
- Dinarello CA. Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr Opin Pharmacol 2004;4:378–385.
- Dana MR, Yamada J, Streilein JW. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation 1997;63:1501–1507.
- Yamada J, Dana MR, Sotozono C et al. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res 2003;76:161–167.
- Evans CH, Robbins PD. The interleukin-1 receptor antagonist and its delivery by gene transfer. Receptor 1994;4:9–15.
- Wolff JA, Malone RW, Williams Pet al Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465–1468.
- Arend WP, Joslin FG, Thompson RC et al. An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties. J Immunol 1989;143:1851–1858.
- Arend WP, Welgus HG, Thompson RC et al. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 1990;85:1694–1697.
- Wilson SE, He YG, Lloyd SA. EGF, EGF receptor, basic FGF, TGF beta-1, and IL-1 alpha mRNA in human corneal epithelial cells and stromal fibroblasts. Invest Ophthalmol Vis Sci 1992;33:1756–1765.
- Weng J, Mohan RR, Li Q et al. IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: interleukin-1 beta expression in the cornea. Cornea 1997;16:465–471.
- Strissel KJ, Rinehart WB, Fini ME. A corneal epithelial inhibitor of stromal cell collagenase synthesis identified as TGF-beta 2. Invest Ophthalmol Vis Sci 1995;36:151–162.
- Torres PF, De Vos AF, van der Gaag R et al. Cytokine mRNA expression during experimental corneal allograft rejection. Exp Eye Res 1996;63:453–461.
- Bragonzi A, Dina G, Villa A et al. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther 2000;7:1753–1760.
- Goula D, Remy JS, Erbacher Pet al Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther 1998;5:712–717.
- Chemin I, Moradpour D, Wieland Set al Liver-directed gene transfer: a linear polyethlenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo. J Viral Hepat 1998;5:369–375.
- Masad I, Matauo T, Yasuda T et al. Gene transfer with liposome to the intraocular tissues by different routes of administration. Invest Ophthalmol Vis Sic 1996;37:1914–1926.
- Stechschulte SU, Joussen AM, Von Recum HA et al. Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest Ophthalmol Vis Sic 2001;42:1975–1979.
- Kamata Y, Okuyama T, Kosuga M et al Adenovirus-mediated gene therapy for corneal clouding in mice with mucopolysaccharidosis type VII. Mol Ther 2001;4:307–312.